Smart D et al. |
'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. |
2002 |
Br. J. Pharmacol. |
pmid:12023948
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Ross RA |
Anandamide and vanilloid TRPV1 receptors. |
2003 |
Br. J. Pharmacol. |
pmid:14517174
|
Vandevoorde S and Fowler CJ |
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. |
2005 |
Br. J. Pharmacol. |
pmid:15895107
|
Malinowska B et al. |
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? |
2012 |
Br. J. Pharmacol. |
pmid:22022923
|
Price TJ et al. |
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. |
2004 |
Br. J. Pharmacol. |
pmid:15006899
|
Mombouli JV et al. |
Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells. |
1999 |
Br. J. Pharmacol. |
pmid:10323591
|
Hind WH et al. |
Endocannabinoids modulate human blood-brain barrier permeability in vitro. |
2015 |
Br. J. Pharmacol. |
pmid:25651941
|
Akerman S et al. |
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. |
2004 |
Br. J. Pharmacol. |
pmid:15277315
|
Thors L and Fowler CJ |
Is there a temperature-dependent uptake of anandamide into cells? |
2006 |
Br. J. Pharmacol. |
pmid:16865094
|
Van den Bossche I and Vanheel B |
Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. |
2000 |
Br. J. Pharmacol. |
pmid:10960073
|
Thors L et al. |
Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. |
2007 |
Br. J. Pharmacol. |
pmid:17676056
|
Smart D et al. |
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). |
2000 |
Br. J. Pharmacol. |
pmid:10694225
|
Al Kury LT et al. |
Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. |
2014 |
Br. J. Pharmacol. |
pmid:24758718
|
Gardener MJ et al. |
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15066906
|
Chicca A et al. |
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors. |
2012 |
Br. J. Pharmacol. |
pmid:22646533
|
Brighton PJ et al. |
Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium. |
2011 |
Br. J. Pharmacol. |
pmid:21486283
|
Gardiner SM et al. |
Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats. |
2009 |
Br. J. Pharmacol. |
pmid:19702785
|
Pertwee RG et al. |
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. |
1993 |
Br. J. Pharmacol. |
pmid:8306090
|
Evans RM et al. |
Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. |
2007 |
Br. J. Pharmacol. |
pmid:17700720
|
Wheal AJ et al. |
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. |
2007 |
Br. J. Pharmacol. |
pmid:17700721
|
Mendiguren A and Pineda J |
Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices. |
2009 |
Br. J. Pharmacol. |
pmid:19845674
|
Zakrzeska A et al. |
A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats. |
2010 |
Br. J. Pharmacol. |
pmid:20105178
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Whyte LS et al. |
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. |
2012 |
Br. J. Pharmacol. |
pmid:21649637
|
Thors L et al. |
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. |
2010 |
Br. J. Pharmacol. |
pmid:20590565
|
Mukhopadhyay P et al. |
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. |
2010 |
Br. J. Pharmacol. |
pmid:20590569
|
Rajesh M et al. |
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. |
2010 |
Br. J. Pharmacol. |
pmid:20590572
|
Wheal AJ et al. |
Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity. |
2010 |
Br. J. Pharmacol. |
pmid:20590573
|
Gutierrez-Lopez MD et al. |
Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. |
2010 |
Br. J. Pharmacol. |
pmid:20590579
|
Smith PJ and McQueen DS |
Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat. |
2001 |
Br. J. Pharmacol. |
pmid:11588121
|
Randall MD |
The cardiovascular actions of anandamide: more targets? |
2005 |
Br. J. Pharmacol. |
pmid:15834438
|
Kwolek G et al. |
Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. |
2005 |
Br. J. Pharmacol. |
pmid:15834445
|
Li Q et al. |
Electrophysiological effects of anandamide on rat myocardium. |
2009 |
Br. J. Pharmacol. |
pmid:20050190
|
Underdown NJ et al. |
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. |
2005 |
Br. J. Pharmacol. |
pmid:16158067
|
Mechoulam R |
Plant cannabinoids: a neglected pharmacological treasure trove. |
2005 |
Br. J. Pharmacol. |
pmid:16205721
|
Thomas A et al. |
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. |
2005 |
Br. J. Pharmacol. |
pmid:16205722
|
Aquila S et al. |
Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. |
2010 |
Br. J. Pharmacol. |
pmid:20067470
|
Ishac EJ et al. |
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. |
1996 |
Br. J. Pharmacol. |
pmid:8864538
|
Bisogno T et al. |
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. |
2001 |
Br. J. Pharmacol. |
pmid:11606325
|
Oliveira L et al. |
Effects of some isoprostanes on the human umbilical artery in vitro. |
2000 |
Br. J. Pharmacol. |
pmid:10711349
|
Steffens M et al. |
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. |
2004 |
Br. J. Pharmacol. |
pmid:14993102
|
Evans RM et al. |
Multiple actions of anandamide on neonatal rat cultured sensory neurones. |
2004 |
Br. J. Pharmacol. |
pmid:15023857
|
Holt S et al. |
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. |
2001 |
Br. J. Pharmacol. |
pmid:11399668
|
Ho WS et al. |
'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. |
2008 |
Br. J. Pharmacol. |
pmid:18695637
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Lee MG et al. |
Effect of olvanil and anandamide on vagal C-fiber subtypes in guinea pig lung. |
2005 |
Br. J. Pharmacol. |
pmid:16056239
|
Movahed P et al. |
Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. |
2005 |
Br. J. Pharmacol. |
pmid:15997233
|
Gaskari SA et al. |
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. |
2005 |
Br. J. Pharmacol. |
pmid:16025138
|
De Petrocellis L et al. |
Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. |
2004 |
Br. J. Pharmacol. |
pmid:15289293
|